Wall Street brokerages expect that Align Technology, Inc. (NASDAQ:ALGN) will post earnings per share (EPS) of $0.83 for the current quarter, according to Zacks. Seven analysts have provided estimates for Align Technology’s earnings. The lowest EPS estimate is $0.81 and the highest is $0.84. Align Technology posted earnings of $1.17 per share in the same quarter last year, which would suggest a negative year over year growth rate of 29.1%. The firm is scheduled to issue its next quarterly earnings report on Wednesday, April 24th.
On average, analysts expect that Align Technology will report full-year earnings of $5.08 per share for the current financial year, with EPS estimates ranging from $4.92 to $5.30. For the next year, analysts expect that the company will report earnings of $7.11 per share, with EPS estimates ranging from $6.66 to $7.65. Zacks’ earnings per share averages are an average based on a survey of research firms that follow Align Technology.
Align Technology (NASDAQ:ALGN) last released its quarterly earnings data on Tuesday, January 29th. The medical equipment provider reported $1.20 EPS for the quarter, topping analysts’ consensus estimates of $1.16 by $0.04. The business had revenue of $534.02 million during the quarter, compared to the consensus estimate of $512.03 million. Align Technology had a return on equity of 33.41% and a net margin of 20.35%.
In other Align Technology news, SVP Julie Tay sold 1,250 shares of the company’s stock in a transaction dated Tuesday, February 12th. The shares were sold at an average price of $254.58, for a total value of $318,225.00. Following the completion of the transaction, the senior vice president now directly owns 11,926 shares of the company’s stock, valued at approximately $3,036,121.08. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Joseph Lacob sold 20,000 shares of the company’s stock in a transaction dated Thursday, February 28th. The shares were sold at an average price of $258.31, for a total transaction of $5,166,200.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 21,650 shares of company stock valued at $5,586,633. 1.40% of the stock is currently owned by corporate insiders.
Large investors have recently bought and sold shares of the business. BlackRock Inc. lifted its position in shares of Align Technology by 31.7% during the fourth quarter. BlackRock Inc. now owns 6,935,085 shares of the medical equipment provider’s stock worth $1,452,414,000 after purchasing an additional 1,670,441 shares during the last quarter. FMR LLC lifted its position in shares of Align Technology by 6.2% during the third quarter. FMR LLC now owns 1,811,522 shares of the medical equipment provider’s stock worth $708,704,000 after purchasing an additional 106,012 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of Align Technology by 22.4% during the fourth quarter. Bank of New York Mellon Corp now owns 1,334,677 shares of the medical equipment provider’s stock worth $279,521,000 after purchasing an additional 244,095 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Align Technology by 0.9% during the fourth quarter. Geode Capital Management LLC now owns 1,057,392 shares of the medical equipment provider’s stock worth $221,101,000 after purchasing an additional 9,617 shares during the last quarter. Finally, Disciplined Growth Investors Inc. MN lifted its position in shares of Align Technology by 1.1% during the third quarter. Disciplined Growth Investors Inc. MN now owns 938,023 shares of the medical equipment provider’s stock worth $366,973,000 after purchasing an additional 9,958 shares during the last quarter. 81.86% of the stock is owned by institutional investors.
Shares of Align Technology stock opened at $247.59 on Friday. Align Technology has a twelve month low of $177.93 and a twelve month high of $398.88. The firm has a market cap of $20.17 billion, a P/E ratio of 50.32, a price-to-earnings-growth ratio of 2.29 and a beta of 2.12.
About Align Technology
Align Technology, Inc designs, manufactures, and markets a system of clear aligner therapy, intraoral scanners, and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services. The company's Clear Aligner segment offers Invisalign Full, a treatment used for a range of malocclusion; Invisalign Teen treatment that addresses orthodontic needs of teenage patients, such as compliance indicators, compensation for tooth eruption, and six free single arch replacement aligners; and Invisalign Assist treatment for anterior alignment and aesthetically-oriented cases.
Featured Article: NASDAQ Stock Market Explained
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.